Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · February 21, 2024

Efficacy and Safety of Elobixibat in Patients With Parkinson's Disease and Chronic Constipation

Movement Disorders Clinical Practice


Additional Info

Movement Disorders Clinical Practice
Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD Study
Mov Disord Clin Pract 2024 Jan 24;[EPub Ahead of Print], T Hatano, G Oyama, Y Shimo, K Ogaki, N Nishikawa, R Nakamura, T Tsunemi, T Ogawa, H Eguchi, K Daida, N Kurita, SI Ueno, J Fukae, W Sako, K Shiina, S Nakajima, Y Oji, R Wakamori, S Saiki, K Nishioka, A Okuzumi, D Taniguchi, H Takeshige-Amano, A Fuse, A Nakajima, M Kano, H Kamo, Y Yamashita, A Shindo, N Yanagisawa, N Hattori

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading